Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Revenue Per Share & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Revenue Per Share

LCTX Revenue Per Share

Current (TTM)0.05retrievedOct 20, 2026

LCTX Revenue per Share (0.03 → 0.05)

Period values, visible window

High-resolution chart · PNG

LCTX revenue per share history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Revenue Per Share — Annual fiscal periods
Period ending	Revenue Per Share
Dec 31, 2025	0.0633
Dec 31, 2024	0.0474
Dec 31, 2023	0.0518
Dec 31, 2022	0.0866
Dec 31, 2021	0.0237
Dec 31, 2020	0.0052
Dec 31, 2019	0.0102
Dec 31, 2018	0.0112
Dec 31, 2017	0.0157
Dec 31, 2016	0.0231
Dec 31, 2015	0.0318
Dec 31, 2014	0.0293
Dec 31, 2013	0.0528
Dec 31, 2012	0.0344
Dec 31, 2011	0.0925
Dec 31, 2010	0.0914
Dec 31, 2009	0.0657
Dec 31, 2008	0.0633
Dec 31, 2007	0.0458
Dec 31, 2006	0.0516
Dec 31, 2005	0.0504
Dec 31, 2004	0.0394
Dec 31, 2003	0.039
Dec 31, 2002	0.0313
Dec 31, 2001	0.0131
Dec 31, 2000	0.0048
Dec 31, 1999	0.0971
Dec 31, 1998	0.03
Jun 30, 1998	0.0113
Jun 30, 1996	0.0128
Jun 30, 1995	0.0125
Jun 30, 1994	0.0167
Jun 30, 1993	0.0192
Jun 30, 1992	0.0257

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.